| Date | Title | Description | |
|---|---|---|---|
| 12 Apr 2021 | On business and financial situation | The Company releases the press release related to its participation in the manufacture of the active substance of Moderna’s COVID-19 vaccine. | Download |
| 02 Mar 2021 | On business and financial situation | The Company releases an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States | Download |
| 02 Mar 2021 | On business and financial situation | The Company releases a presentation related to an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States | Download |
| 24 Feb 2021 | About corporate governance | The Company informs about the agreements adopted by the Board of Directors | Download |
| 27 Nov 2020 | On business and financial situation | The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 07 Nov 2024 | On P&L | A correction to the English version of a document is reported. | Download |
| 03 Oct 2024 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the third quarter of 2024 | Download |
| 12 Sep 2024 | Other relevant information | The Company announces the registration in the Commercial Registry of the public deed of reduction of its share capital and the new share capital figure. | Download |
| 01 Aug 2024 | Other relevant information | The Company has agreed to execute the share capital reduction approved by the 2024 Ordinary General Meeting to amortize treasury shares, among which those acquired in the framework of the own shares repurchase program. | Download |
| 31 Jul 2024 | Liquidity and counterparty agreements | Modification of securities and cash balances associated with the Liquidity Contract signed between the Company and Bestinver, S.V., S.A. | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 31 Jan 2020 | R&D: new licenses, patents and registered trademarks | The Company informs about the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union | Download |
| 08 Jan 2020 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the fourth quarter of 2019 | Download |
| 20 Dec 2019 | Composition of the board of directors | The Company informs about the composition of its Board of Directors and its Audit and Appointments and Remuneration Committees. | Download |
| 24 Nov 2019 | Strategic plans, profit forecasts and presentations | The Company releases the presentation related to its strategy update because of the 2019 Investor Day. | Download |
| 07 Nov 2019 | Information on P&L | ROVI releases the press release related to the first nine months 2019 financial results | Download |